Laboratoire Aguettant SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratoire Aguettant SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10655
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratoire Aguettant SA (Aguettant) is a pharmaceutical company that that focuses on the development, manufacturing and commercialisation of injectable hospital medicines. The company offers sterile injectable medicines in various dosages and pharmaceutical forms. It provides its products for irrigation and urology, rinsing and care, and electrolyte solutions in plastic ampoules. Aguettant’s products are used for the treatment of hypotension, bradycardia, cardiac arrests, general and locoregional anaesthesia, and Parkinson’s disease. The company sells its products through a network of distributors located across the world. It has operations in France, Belgium, Germany, Austria, Spain, Singapore, the UK and Ireland, and Italy. Aguettant is headquartered in Lyon, France.

Laboratoire Aguettant SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Laboratoire Aguettant to Acquire Commercialization Right of Monover in France 10
Licensing Agreements 11
Baxter International Enters into Agreement with Laboratoire Aguettant 11
Acquisition 12
Aguettant Acquires Majority Stake In PX’Therapeutics 12
Laboratoire Aguettant SA – Key Competitors 13
Laboratoire Aguettant SA – Key Employees 14
Laboratoire Aguettant SA – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratoire Aguettant SA, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratoire Aguettant to Acquire Commercialization Right of Monover in France 10
Baxter International Enters into Agreement with Laboratoire Aguettant 11
Aguettant Acquires Majority Stake In PX'Therapeutics 12
Laboratoire Aguettant SA, Key Competitors 13
Laboratoire Aguettant SA, Key Employees 14
Laboratoire Aguettant SA, Subsidiaries 15

List of Figures
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laboratoire Aguettant SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Digital China Holdings Limited:企業の戦略・SWOT・財務分析
    Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Novanta Inc (NOVT):医療機器:M&Aディール及び事業提携情報
    Summary Novanta Inc (Novanta), formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam de …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Gould Paper Corp:企業の戦略的SWOT分析
    Gould Paper Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Benihana Inc.:企業の戦略・SWOT・財務情報
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Second Genome Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Second Genome Inc (Second Genome), formerly PhyloTech Inc, is a clinical stage pharmaceutical company that provides microbial research and drug discovery services. The company’s pipeline products include SGM-1019, a small molecule inhibitor targeting tissue injury and inflammation; and SG-2- …
  • Envestnet, Inc.:企業のM&A・事業提携・投資動向
    Envestnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Envestnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Pakistan Oilfields Ltd (POL):企業の財務・戦略的SWOT分析
    Pakistan Oilfields Ltd (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • EyePoint Pharmaceuticals Inc (PSDV):製薬・医療:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • China Aviation Oil (Singapore) Corp Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corp Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • SINTX Technologies Inc (SINT):企業の財務・戦略的SWOT分析
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Fauji Fertilizer Co Ltd (FFC):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Co Ltd (FFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PacifiCorp:企業の発電所・SWOT分析2018
    PacifiCorp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Essar Power Limited-エネルギー分野:企業M&A・提携分析
    Summary Essar Power Limited (Essar Power), a subsidiary of Essar Energy Limited, is a power utility which produces electricity and thermal energy. It generates power from coal, natural gas, and co-generation plants. The company owns and operates power generation plants in India and Canada. Through i …
  • Medical Depot Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medical Depot Inc (Drive Medical) is a manufacturer and distributor of durable medical equipment. The company provides rollators, walkers, canes and crutches, commodes, bath safety, patient room , wheelchairs, power mobility, beds, pressure prevention, electrotherapy, lifestyle essentials, r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆